Adam M Veness Insider Profile
4 Followers
Adam M Veness, SVP, GC and Sec at Dianthus Therapeutics, holds 15.00K shares in Dianthus Therapeutics (Ticker: DNTH), holds 0.00 shares in Acceleron Pharma (Ticker: XLRN), holds ― shares in Cyteir Therapeutics (Ticker: CYT).
Adam M Veness has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
SVP, GC and Sec
Roles that Adam M Veness holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Adam M Veness
Adam M Veness's Trading History
Dianthus Therapeutics
Aug 14, 2026
SVP, GC and Sec
Uninformative Buy
272.55K
$1.59M
Acceleron Pharma
Nov 22, 2021
―
Uninformative Sell
―
$0.00
Cyteir Therapeutics
―
―
―
―
List of latest transactions for each holding click on a transaction to see Adam M Veness's performance on stock
You May Also Like
Adam M Veness insider profile FAQ
What is the percentage of profitable transactions made by Adam M Veness?
The percentage of profitable transactions made by Adam M Veness is ―.
What is the average return per transaction made by Adam M Veness?
The average return per transaction made by Adam M Veness is ―.
What stocks does Adam M Veness hold?
Adam M Veness holds: DNTH, XLRN, CYT stocks.
What was Adam M Veness’s latest transaction?
Adam M Veness latest transaction was an Uninformative Buy of $272.55K.
What was Adam M Veness's most profitable transaction?
Adam M Veness’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Adam M Veness's role in Dianthus Therapeutics?
Adam M Veness's role in Dianthus Therapeutics is SVP, GC and Sec.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.